Impedimed Limited (AU:IPD) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
ImpediMed Limited has announced a change in director Ms. Janelle Delaney’s interests in the company, with an increase of 152,468 ordinary shares acquired indirectly. This adjustment results from the issuance of shares in lieu of 30% of her director fees for the quarter ending September 2024. The transaction reflects a strategic decision to align director compensation with shareholder interests.
For further insights into AU:IPD stock, check out TipRanks’ Stock Analysis page.
